Prevention of Contrast Induced Nephropathy after Endovascular Therapy combined with Carbon Dioxide-digital subtraction angiography in Patients With Ilio-Femoropopliteal artery diseases

Prevention of Contrast Induced Nephropathy after Endovascular Therapy combined with Carbon Dioxide-digital subtraction angiography in Patients With Ilio-Femoropopliteal artery diseases - CineCD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011988

Enrollment

100

Registered

2013-10-08

Start date

2013-10-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral artery disease

Interventions

Randomized Control arm With 60&gt

eGFR&gt

or=30 mL/min/1.73 m2: contrast media-digital subtraction angiography Randomized CO2 usage arm With 60&gt

or=30 mL/min/1.73 m2: contrast media combined with Carbon Dioxide digital subtraction angiography intervention CO2 usage arm with eGFR&lt

30 mL/min/1.73 m2: contrast media combined with Carbon Dioxide digital subtraction angiography

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: PAD patient recommended endovascular therapy in Patients With Ilio-Femoropopliteal artery diseases and estimated Glomerular Filtration Rate is less than 60ml/min./1.73m2. not exclusion criteria patient. patients with agreement for this study.

Exclusion criteria

Exclusion criteria: 1)Life expectancy 6 months. 2)without regular dialysis 3)under 30years old 4)inappropriate patient determined from study director. 5)patient unavailable of anti platelet agents and anticoagulant. 6)Allergy of contrast agents.

Design outcomes

Primary

Measure	Time frame
Incidence of Contrast Induced Nephropathy	—

Secondary

Measure	Time frame
1)Safety of Endovascular Therapy with Carbon Dioxide-digital subtraction angiography(DSA) 2)Comparison of ABI change after Endovascular Therapy 3)volume of contrast media, injection volume of Carbon Dioxide, Procedure time, Endovascular Therapy related complication 4)comparison of final angiography in Endovascular Therapy	—

Countries

Japan

Contacts

Public ContactClinical Trials Support Office

Sakakibara Heart Institute Clinical Trials Support Office

tikenjim@shi.heart.or.jp042-314-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026